Tuesday, April 16, 2024 2:25:17 PM
They are restating their financials losing / removing the land purchase they had supposedly done ( was it South Carolina?) reducing their overall assets. Also stating they don’t have enough money to get people to to control / manage disclosures (I’m assuming 10Qs and 10Ks) and they don’t have enough external independent directors ? Well that’s not good also if they want to do Nasdaq eh?
At least they had the foresight to set expectations. SMH.
Of course maybe they are spending all money and effort for vume? …
“The impact of this restatement on the Company's third quarter 2023 unaudited condensed consolidated financial statements will be a $1,226,000 decrease in Total Assets and $1,226,000 decrease in Mezzanine Equity on the Condensed Consolidated Balance Sheet as of September 30, 2023. There is no effect on the Condensed Consolidated Statement of Operations, Condensed Consolidated Statement of Stockholders Deficit or Condensed Consolidated Statement of Cash Flows for the three and nine months ended September 30, 2023.
The Company entered into an agreement to acquire land per the Real estate Land Purchase and JV Real estate Development Partnership Agreement dated July 14, 2023. It was management’s understanding the due diligence was completed and that the Company could record the acquisition on its books and records as of this date. Subsequently, the Company learned of an undisclosed mortgage on the subject land that would have impaired the land and also discovered the inability to use as consideration its Series E Preferred Stock. Both parties on April 12, 2024 agreed to cancel the transaction.
Management has determined that the errors described above do not change management's previous conclusions regarding the effectiveness of the Company's disclosure controls and procedures as of September 30, 2023. Due to the lack of personnel and outside directors, management concluded that the Company’s disclosure controls and procedures are not effective as of such date. The Company anticipates that with further resources, the Company will expand both management and the board of directors with additional officers and independent directors in order to provide sufficient disclosure controls and procedures.”
Recent TPTW News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 04:40:08 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 08/12/2024 05:39:45 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/24/2024 04:15:03 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 07/17/2024 01:26:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 05:52:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 09:17:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/28/2024 02:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 09:18:29 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/10/2024 09:24:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 10:18:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 07:47:35 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/13/2024 06:17:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:00:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 09:52:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 08:06:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/27/2023 08:11:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 05:43:43 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM